Wiggin and Dana Sample Contracts

Stock Purchase Agreement (August 9th, 2017)

This Stock Purchase Agreement (this "Agreement"), dated as of August 9, 2017, is entered into by and among AIRGAS, INC., a Delaware corporation ("Seller"), HUDSON HOLDINGS, INC., a Nevada corporation ("Buyer"), and HUDSON TECHNOLOGIES, INC., a New York corporation ("Buyer Parent").

Asset Purchase Agreement (July 26th, 2017)

THIS ASSET PURCHASE AGREEMENT, dated as of July 25, 2017 (this "Agreement"), is by and between SunTech Medical Inc., a North Carolina corporation ("Buyer"), and CAS Medical Systems, Inc., a Delaware corporation ("CASMED" or "Seller"). Buyer and Seller are sometimes collectively referred to herein as the "Parties". Any defined terms not otherwise defined in a particular section shall have the meanings set forth in Section 8.

Esquire Financial Holdings, Inc. – Registration Rights Agreement (May 31st, 2017)

THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of December 23, 2014 by and between Esquire Financial Holdings, Inc., a Delaware corporation and parent company of Esquire Bank (the "Company"), and CJA Private Equity Financial Restructuring Master Fund I, LP, a Cayman Islands limited partnership ("Investor"). For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and Investor hereby agree as follows:

Employment Agreement (December 19th, 2016)

This EMPLOYMENT AGREEMENT (this "Agreement") is entered into on December 15, 2016 (the "Effective Date") by and between MISONIX, INC., a New York corporation, with principal offices at 1938 New Highway, Farmingdale, New York 11735 ("Employer"), and STAVROS G. VIZIRGIANAKIS, with an address at No. 16 Idle Wild, 33 Outspan Road, Riverclub, Gauteng 2191 South Africa ("Executive").

Asset Purchase Agreement by and Among Tetralogic Pharmaceuticals Corporation, Tetralogic Research and Development Corporation and Medivir Ab Dated as of November 2, 2016 (November 3rd, 2016)

This Asset Purchase Agreement (this Agreement) is made and entered into as of this 2nd day of November, 2016 by and among TetraLogic Pharmaceuticals Corporation, a Delaware corporation (TLOG), TetraLogic Research and Development Corporation, a Delaware corporation (TR&D and, collectively with TLOG, the Sellers), and Medivir AB, a Swedish corporation (the Buyer).

Asset Purchase Agreement by and Among Tetralogic Pharmaceuticals Corporation, Tetralogic Research and Development Corporation and Medivir Ab Dated as of November 2, 2016 (November 3rd, 2016)

This Asset Purchase Agreement (this Agreement) is made and entered into as of this 2nd day of November, 2016 by and among TetraLogic Pharmaceuticals Corporation, a Delaware corporation (TLOG), TetraLogic Research and Development Corporation, a Delaware corporation (TR&D and, collectively with TLOG, the Sellers), and Medivir AB, a Swedish corporation (the Buyer).

Stock Purchase Agreement (October 25th, 2016)

This STOCK PURCHASE AGREEMENT (this "Agreement") is made and entered into as of October 25, 2016, by and between MISONIX, INC., a New York corporation with its principal offices at 1938 New Highway, Farmingdale, New York 11735 (the "Company"), and Stavros G. Vizirgianakis with an address at No. 16, Idle Wild, 33 Outspan Road, Riverclub, Gauteng 2191 South Africa (the "Investor").

Confidential Securities Purchase Agreement (August 29th, 2016)

THIS SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated on and as of the latest date set forth on the signature page hereto, by and between Virtual Piggy, Inc., a Delaware corporation (the "Company"), and the purchaser identified on the signature page hereof ("Purchaser").

Contract (August 29th, 2016)

THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE. THIS NOTE HAS BEEN TAKEN BY THE REGISTERED OWNER FOR INVESTMENT, AND WITHOUT A VIEW TO RESALE OR DISTRIBUTION THEREOF, AND MAY NOT BE SOLD, TRANSFERRED OR DISPOSED OF WITHOUT AN OPINION OF COUNSEL SATISFACTORY TO THE ISSUER THAT SUCH TRANSFER OR DISPOSITION DOES NOT VIOLATE THE SECURITIES ACT OF 1933, AS AMENDED, THE RULES AND REGULATIONS THEREUNDER OR OTHER APPLICABLE SECURITIES LAWS.

Customers Bancorp – Transition Services Agreement (June 16th, 2016)

This TRANSITION SERVICES AGREEMENT (this "Agreement") is made as of June !5, 2016 between Higher One, Inc., a Delaware corporation ("Seller") and Customers Bank, a bank chartered under the laws of the Commonwealth of Pennsylvania ("Buyer"). Seller and Buyer are referred to herein collectively as the "Parties" and individually as a "Party."

Higher One Holdings – ASSET PURCHASE AGREEMENT Between HIGHER ONE, INC. And CL NEWCO, INC. Dated as of October 14, 2015 (March 15th, 2016)

This Asset Purchase Agreement (this "Agreement"), dated as of October 14, 2015, is entered into between Higher One, Inc., a Delaware corporation ("Seller") and CL NewCo, Inc., a Delaware corporation ("Buyer").

Warrant to Purchase Common Stock (November 6th, 2015)

This WARRANT ("Warrant") is to verify that, FOR VALUE RECEIVED, [_________________] ("Holder") is entitled to purchase, subject to the terms and conditions hereof, from Virtual Piggy, Inc. a Delaware corporation (the "Company"), [_____________] shares of common stock, $0.0001 par value per share, of the Company (the "Common Stock"), at any time during the period commencing at 9:00 a.m., Eastern Time on the date hereof (the "Commencement Date") and ending at 5:00 p.m. Eastern Time on _____[__], 201[_] (the "Termination Date"), at an exercise price (the "Exercise Price") of $1.00 per share of Common Stock. The number of shares of Common Stock purchasable upon exercise of this Warrant and the Exercise Price per share shall be subject to adjustment from time to time upon the occurrence of certain events as set forth below.

Surgiquest Inc – Credit and Security Agreement (October 13th, 2015)

THIS CREDIT AND SECURITY AGREEMENT (this Agreement), dated as of May 29, 2014 (the Closing Date) by and among MIDCAP FUNDING V, LLC, a Delaware limited liability company (MidCap), as administrative agent (Agent), the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a Lender, and collectively the Lenders), and SURGIQUEST, INC., a Delaware corporation (Borrower), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay Lenders. The parties agree as follows:

UIL HOLDINGS CORPORATION as the Company and THE BANK OF NEW YORK MELLON as Trustee Subordinated Indenture (March 9th, 2015)

SUBORDINATED INDENTURE, dated as of , 20 , between UIL Holdings Corporation, a Connecticut corporation, as the Company, and The Bank of New York Mellon, a corporation organized under the laws of the State of New York authorized to conduct a banking business, as Trustee.

Broadway Financial Corporation – Registration Rights Agreement (November 13th, 2014)

THIS REGISTRATION RIGHTS AGREEMENT (this Agreement) is made as of October 16, 2014, between Broadway Financial Corporation, a Delaware corporation and parent company of Broadway Federal Bank, f.s.b (the Company), on the one hand, and Gapstow Financial Growth Capital Fund I LP, a Delaware limited partnership, and National Community Investment Fund, a trust (each an Investor and, collectively, the Investors), on the other hand. For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and the Investor hereby agree as follows:

Uluru Inc – Registration Rights Agreement (March 31st, 2014)

THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made as of the 31st day of January, 2014, by and among ULURU Inc., a Nevada corporation (the "Company"), Michael Sacks ("Sacks") and The Punch Trust ("TPT," and together with Sacks and any party added to this Agreement pursuant to Section 3.13, the "Investors").

Streamline Health Solutions, Inc. – Software License and Royalty Agreement (December 17th, 2013)

This document and its attachments contain certain terms of agreement between Streamline Health, Inc., a corporation organized under the laws of Ohio, with offices located at 1230 Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309 ("Streamline") and the Montefiore Medical Center, a not-for-profit corporation organized under the laws of New York, with offices located at 111 East 210 Street, Bronx, New York 10467 ("Montefiore").

License Agreement (November 8th, 2013)

This LICENSE AGREEMENT (the "Agreement") is executed as of July 17, 2013 (the "Effective Date") by and between Ligand Pharmaceuticals Incorporated, a corporation organized under the laws of Delaware and having a place of business at 11119 North Torrey Pines Road, Suite 200, La Jolla, CA, 92037 ("Ligand") and Azure Biotech, Inc., a corporation organized under the laws of Delaware and having a place of business at 500 East 85th Street, 19D, New York, NY, 10028 ("Licensee"). Ligand and Licensee are each referred to herein by name or, individually, as a "Party" or, collectively, as "Parties."

Higher One Holdings – ASSET PURCHASE AGREEMENT BETWEEN SALLIE MAE, INC. (The "Seller") AND HIGHER ONE, INC. (The "Buyer") May 7, 2013 (August 9th, 2013)

This ASSET PURCHASE AGREEMENT (this "Agreement") is entered into as of May 7, 2013 between Sallie Mae, Inc., a Delaware corporation (the "Seller") and Higher One, Inc., a Delaware corporation (the "Buyer"). The Seller and the Buyer are referred to herein individually as a "Party" and collectively as the "Parties."

Strategic Environmental & Energy Resources, Inc. – Form of Convertible Secured Promissory Note (July 23rd, 2013)
Strategic Environmental & Energy Resources, Inc. – Form of Convertible Secured Promissory Note (June 28th, 2013)

FOR VALUE RECEIVED, Strategic Environmental & Energy Resources, Inc., a Nevada corporation with offices at 7801 Brighton Road, Commerce City, Colorado 80022 ("SEER"), and MV, LLC a Colorado limited liability company and wholly owned subsidiary of SEER with offices at 701 Pine Ridge Road, Suite 5, Golden, Colorado 80403 ("MV", and together with SEER, the "Makers"), hereby promise, jointly and severally, to pay to the order of Advanced Technology Materials, Inc., a Delaware corporation with offices at 7 Commerce Drive, Danbury, Connecticut 06810 (the "Holder"), the principal sum of TWO HUNDRED TWENTY-FIVE THOUSAND AND 00/100 UNITED STATES DOLLARS (US$225,000), plus interest thereon as hereinafter provided, in immediately available funds. The principal sum and interest thereon under this Convertible Secured Promissory Note (this "Note") shall be payable as described below. This Note is issued pursuant to that certain Loan Agreement dated as of February 14, 2012 by and among the Makers and

Strategic Environmental & Energy Resources, Inc. – Form of Convertible Secured Promissory Note (May 21st, 2013)

FOR VALUE RECEIVED, Strategic Environmental & Energy Resources, Inc., a Nevada corporation with offices at 7801 Brighton Road, Commerce City, Colorado 80022 ("SEER"), and MV, LLC a Colorado limited liability company and wholly owned subsidiary of SEER with offices at 701 Pine Ridge Road, Suite 5, Golden, Colorado 80403 ("MV", and together with SEER, the "Makers"), hereby promise, jointly and severally, to pay to the order of Advanced Technology Materials, Inc., a Delaware corporation with offices at 7 Commerce Drive, Danbury, Connecticut 06810 (the "Holder"), the principal sum of TWO HUNDRED TWENTY-FIVE THOUSAND AND 00/100 UNITED STATES DOLLARS (US$225,000), plus interest thereon as hereinafter provided, in immediately available funds. The principal sum and interest thereon under this Convertible Secured Promissory Note (this "Note") shall be payable as described below. This Note is issued pursuant to that certain Loan Agreement dated as of February 14, 2012 by and among the Makers a

Lease We Route 34, Llc (Landlord) and Alexion Pharmaceuticals, Inc. (Tenant) Dated: As of November 15, 2012 (April 30th, 2013)

AGREEMENT OF LEASE dated as of the 15th day of November, 2012 (the "Effective Date", between WE ROUTE 34, LLC, a Delaware limited liability company, with an office at c/o Winstanley Enterprises, LLC, 150 Baker Street Extension, Suite 303, Concord Massachusetts 01742 ("Landlord"), and ALEXION PHARMACEUTICALS, INC., a Delaware corporation with offices at 352 Knotter Drive, Cheshire, Connecticut 06410 ("Tenant").

hdl therapeutics – License Agreement (April 12th, 2013)

THIS LICENSE AGREEMENT (this Agreement), dated as of April 28, 2008 (the Effective Date), as amended on November 17, 2010, is by and between Esperion Therapeutics, Inc., a Delaware corporation (Esperion), and Pfizer, Inc., a Delaware corporation (Pfizer). Esperion and Pfizer are individually referred to herein as a Party, and collectively referred to herein as the Parties.

Notice to Offerees (April 3rd, 2013)

THIS SECURITIES PURCHASE AGREEMENT (this "Agreement"), dated on and as of the latest date set forth on the signature page hereto, by and between Virtual Piggy, Inc., a Delaware corporation (the "Company"), and the purchasers listed on the Schedule of Purchasers attached hereto (each a "Purchaser" and collectively, the "Purchasers").

Vivus, Inc. – Transition Services Agreement (February 26th, 2013)

THIS TRANSITION SERVICES AGREEMENT (this Agreement) is entered into as of November 5, 2010 (the Effective Date) by and between MEDA AB, a corporation organized under the laws of Sweden (MEDA), and VIVUS, Inc., a corporation organized under the laws of Delaware (VIVUS). MEDA and VIVUS may be referred to herein individually as a Party or collectively as the Parties.

Enzon Pharmaceuticals, Inc. – License and Collaboration Agreement (November 9th, 2012)

THIS LICENSE AND COLLABORATION AGREEMENT (the "Agreement") is entered into this 26th day of July 2006 (the "Effective Date") by and between Santaris Pharma A/S, a Danish corporation having its principal place of business at Horsholm, Denmark ("Santaris"), and Enzon Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at Bridgewater, New Jersey 08807 ("Enzon"). Santaris and Enzon may be referred to herein individually as a "Party" or collectively, as the "Parties".

Higher One Holdings – ASSET PURCHASE AGREEMENT by and Between Campus Labs, LLC (The "Target") and the Members of Campus Labs, LLC (The "Members" And, Together With the Target, the "Sellers") and Higher One, Inc. (The "Buyer") Dated as of August 7, 2012 (November 8th, 2012)
CREDIT AGREEMENT Dated as of October 31, 2012 Among UIL HOLDINGS CORPORATION as the Borrower THE BANKS NAMED HEREIN as Banks and JPMORGAN CHASE BANK, N.A. As Administrative Agent (November 5th, 2012)
Access Pharmaceuticals Inc. – Investor Rights Agreement (October 26th, 2012)

This Agreement is being entered into pursuant to the Preferred Stock and Warrant Purchase Agreement, dated as of October 25, 2012, by and among the Company and the Purchasers (the "Purchase Agreement").

Higher One Holdings – Credit Agreement (October 18th, 2012)

This CREDIT AGREEMENT is entered into as of October 16, 2012, among HIGHER ONE, INC., a Delaware corporation (the "Borrower"), the Guarantors (defined herein), the Lenders (defined herein), and BANK OF AMERICA, N.A., as Administrative Agent, Swingline Lender and L/C Issuer.

AGREEMENT AND PLAN OF MERGER by and Among: ZAYO GROUP, LLC, a Delaware Limited Liability Company; VOILA SUB, INC., a Delaware Corporation; And ABOVENET, INC., a Delaware Corporation Dated as of March 18, 2012 (March 19th, 2012)

THIS AGREEMENT AND PLAN OF MERGER (as may be amended from time to time, this Agreement) is made and entered into as of March 18, 2012, by and among: ZAYO GROUP, LLC, a Delaware limited liability company (Parent); Voila Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (Merger Sub); and ABOVENET, INC., a Delaware corporation (the Company). Certain capitalized terms used in this Agreement are defined in Exhibit A.

$31,000,000 2.98% Senior Notes, Series A, Due January 30, 2019 $51,500,000 3.61% Senior Notes, Series B, Due January 31, 2022 $34,000,000 3.61% Senior Notes, Series C, Due January 31, 2022 $52,000,000 4.89% Senior Notes, Series D, Due January 30, 2042 $35,000,000 4.89% Senior Notes, Series E, Due January 30, 2042 Note Purchase Agreement Dated as of January 30, 2012 (February 1st, 2012)

The United Illuminating Company, a specially chartered Connecticut corporation (the "Company"), agrees with each of you (sometimes individually a "Purchaser" and collectively the "Purchasers") as follows:

The Southern Connecticut Gas Company $25,000,000 3.88% Secured Medium-Term Notes, Series Mtn-Iv (Constituting a Series of First Mortgage Bonds) Due September 22, 2021 $25,000,000 5.39% Secured Medium-Term Notes, Series Mtn-Iv (Constituting a Series of First Mortgage Bonds) Due September 22, 2041 Note Purchase Agreement Dated August 29, 2011 (September 1st, 2011)

The Southern Connecticut Gas Company, a Connecticut corporation (the "Company"), agrees with each of the purchasers whose name appears in the attached Schedule A (each, a "Purchaser" and collectively, the "Purchasers") as follows:

CytRx – Asset Purchase Agreement (August 9th, 2011)

This Asset Purchase Agreement (this "Agreement") is made as of May 13, 2011, by and between CytRx Corporation, a Delaware corporation ("Seller"), and Orphazyme ApS, a company organized under the laws of Denmark ("Buyer"). Seller and Buyer are each referred to individually as a "Party" and collectively as the "Parties."